Condition
Delayed Cerebral Ischemia clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Delayed Cerebral Ischemia clinical trials that are recruiting, at sites in 6 countries (most in United States (1), Netherlands (1), Denmark (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Delayed Cerebral Ischemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Metabolomics biomarkers to predict outcomes after subarachnoid hemorrhage | — | Lisbon, Lisbon District | Recruiting | Oct 8, 2026 |
| Understanding brain and heart injuries after bleeding in the brain | — | Beijing, Beijing Municipality | Recruiting | Apr 2, 2025 |
| Tocilizumab-aazg to reduce stroke risk after a ruptured brain aneurysm | Phase 1 | Gainesville, Florida | Recruiting | Mar 7, 2025 |
| Daily IV dornase alfa after a ruptured brain aneurysm to improve independence at six months. | Phase 2 | Grenoble, Grenoble and 5 other locations | Recruiting | Dec 9, 2024 |
| Using limb occlusion therapy to improve recovery in patients with aneurysmal subarachnoid hemorrhage | — | Aarhus N, Danmark | Recruiting | Sep 13, 2023 |
| Using Nadroparin to Improve Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Amsterdam | Recruiting | Aug 11, 2020 |
All recruiting trials (6)
-
Metabolomics biomarkers to predict outcomes after subarachnoid hemorrhage
This study tests whether blood and CSF biomarkers, together with clinical data, can predict recovery a year after spontaneous subarachnoid hemorrhage in adults treated in Lisbon.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
Tocilizumab-aazg to reduce stroke risk after a ruptured brain aneurysm
This trial will try to see if a single IV dose of tocilizumab-aazg is safe and can help prevent delayed strokes in adults who have had a ruptured brain aneurysm (aneurysmal subarachnoid hemorrhage).
-
Daily IV dornase alfa after a ruptured brain aneurysm to improve independence at six months.
This test will try daily intravenous dornase alfa in people with aneurysmal subarachnoid hemorrhage to see if it helps them be more functionally independent at six months.
-
Using limb occlusion therapy to improve recovery in patients with aneurysmal subarachnoid hemorrhage
This study is testing if a special therapy that temporarily restricts blood flow to the arms or legs can help people recover better after having a brain bleed caused by an aneurysm.
-
Using Nadroparin to Improve Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage
This study is testing if giving higher doses of Nadroparin can help patients who have had an aneurysmal subarachnoid hemorrhage live longer and have better recovery outcomes compared to standard doses.
Related topics
Quick answers
How many Delayed Cerebral Ischemia clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (1 trial), Netherlands (1 trial), Denmark (1 trial), Portugal (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.